Recreol cream 50mg/g 50g №1

Name:
RECREOL. International non-proprietary name Dexpanthenol. Dosage formCream for external use 50 mg/g. Composition 1 g of cream contains: active substance – dexpanthenol 50 mg, excipients: DL-pantolactone; phenoxyethanol; potassium cetyl phosphate; lanolin (sheep fat); propylene glycol; stearyl alcohol; cetyl alcohol; isopropyl myristate; purified water up to 1 g.
Description:
Homogeneous white or yellowish cream with a specific odor. Pharmacotherapeutic groupDermatology. Preparations for the treatment of wounds and ulcers. Wound healing drugs. Wound healing drugs, others. Dexpanthenol. ATC code D03AX03 Pharmacological properties RECREOL® cream (RECREOL®) contains the active substance dexpanthenol, which belongs to the group of drugs for the treatment of wounds and ulcers. Dexpanthenol, also known as provitamin B5, helps speed up the healing process in wounds. In tissues, it is converted to pantothenic acid. Pantothenic acid restores skin elasticity and accelerates wound healing. Pharmacokinetics Absorption Dexpanthenol is rapidly absorbed in the skin, immediately converted to pantothenic acid, which is widely distributed in body tissues, mainly in the form of coenzyme A. Distribution After topical application of the drug, pantothenic acid is concentrated in the hair, hair roots, nails, epidermis and dermis. Withdrawal Pantothenic acid is excreted mainly unchanged in the urine and to a lesser extent in the feces. Pharmacodynamics Dexpanthenol in tissues is converted to pantothenic acid, which is an integral part of coenzyme A (CoA) and plays an important role in maintaining the normal function of the epithelium, increasing fibroblast proliferation and accelerating skin regeneration in the process of wound healing. This process of cell division and formation of new skin tissues restores skin elasticity and stimulates wound healing. Indications for use For the treatment of superficial skin lesions (small burns and cracks in the skin, abrasions and cracks in the skin), inflammation of the skin (which occurs when exposed to radiation therapy, phototherapy or ultraviolet radiation). Method of application and doses For external use. Usually the cream is applied in a thin layer to the damaged area of the skin once or several times a day. The duration of the course of treatment depends on the nature and severity of the disease. Dexpanthenol is applied topically one to several times a day. Patients with impaired renal and hepatic activity Studies have not been conducted in patients with impaired renal and hepatic activity. Elderly patients No studies have been conducted in elderly patients (aged 65 years and older). Use in children Dexpanthenol can be used in children. Most studies of topical effects of dexpanthenol have been short-term, typically 3-4 weeks. Side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Very rare (may affect up to 1 in 10,000 people): – allergic reactions – allergic skin reactions – contact dermatitis – allergic dermatitis – itching – reddening of the skin – eczema – rashes – hives – skin irritation and ulcers. If the listed side effects appear, as well as if side effects appear that are not mentioned in the instructions, you should consult a doctor. Contraindications – hypersensitivity to dexpanthenol or any other excipient of the drug; – dexpanthenol is contraindicated for use on wounds in patients with hemophilia, due to the high risk of bleeding. If you have any of the above conditions, inform your doctor before using the drug. Drug interactions No interaction studies have been conducted with dexpanthenol. Interactions are unknown. There is no evidence of an interaction of dexpanthenol with any other drugs. Special instructions Avoid accidental contact with dexpanthenol in the eyes. Dexpanthenol should be discontinued if signs of an allergic reaction occur. Patients should consult their physician if they do not feel better or feel worse after 14 days of use. RECREOL® Cream contains propylene glycol, which may cause skin irritation. RECREOL® cream contains lanolin and cetyl alcohol, which can cause local skin reactions (eg contact dermatitis). Pregnancy, lactation and fertility Pregnancy Studies of the possible effects of dexpanthenol on reproduction have not been conducted. There are no data on the use of dexpanthenol in pregnant women. Animal studies show no direct or indirect harmful effects on reproductive toxicity. Breast-feeding period No effect on breast-fed neonates/infants is expected, since the systemic exposure of a breast-feeding woman to dexpanthenol is negligible. RECREOL® cream can be used during breastfeeding. Fertility Studies of the effects of dexpanthenol on human fertility have not been conducted. Effects on fetal development are not known. If you are pregnant or breastfeeding, inform your doctor. Features of the influence of the drug on the ability to drive a vehicle or potentially dangerous mechanisms Does not affect. Overdose Cases of overdose are not available to humans. Even if an excessive amount of dexpanthenol is used, it has low toxicity and does not cause undesirable side effects that threaten the health of the patient. Release form and packaging 30 g or 50 g of the drug are placed in aluminum tubes with an inner surface coated with varnish, with a protective aluminum membrane on the neck and a cone-shaped device for piercing the membrane in a screw-on plastic bush. The tube, together with instructions for medical use in the state and Russian languages, is placed in a pack of cardboard box. Storage conditions Do not freeze! Store at a temperature not exceeding 25 °C. Keep out of the reach of children! Shelf life 2 years. Do not use after the expiration date. Terms of dispensing from pharmaciesWithout a prescription. ManufacturerJSC “Grindeks”, Latvia. Buy Recreol cream 50mg/g 50g №1 Price for Recreol cream 50mg/g 50g №1Instruction for use for Recreol cream 50mg/g 50g №1